Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alignment Healthcare, Inc.ALHC · Entity 4269 | Director · Chief Executive Officer | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alignment Healthcare, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 590,766 |
Reported balance
After 2026-09-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-14 · Sale · Disposed 27,400 · Balance 590,766 F1: Date of Rule 10b5-1 plan adoption: 05/27/2026 F2: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. |
| Common StockSEC Table I · non-derivative | Direct | 1,223,473 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,223,473 |
Filing footnotes · ownership attribution and instrument terms
F1: Date of Rule 10b5-1 plan adoption: 05/27/2026
F2: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 13, 2025 Filed Jan 13, 2025 23:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 37,614 | $13.41 | $504,471.45 |
DisclosureSEC source: 0001628280-25-001403 · wk-form4_1736810045.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,273,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.24 to $13.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 52,386 | $12.81 | $671,022.75 |
DisclosureSEC source: 0001628280-25-001403 · wk-form4_1736810045.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,310,714 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.23 to $13.22. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:40 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $11.65 | $1,048,689.00 |
DisclosureSEC source: 0001628280-24-051238 · wk-form4_1734129631.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,363,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.44 to $11.81. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 22:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $13.42 | $1,207,944.00 |
DisclosureSEC source: 0001628280-24-047669 · wk-form4_1731536040.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,453,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 22:57 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $11.33 | $1,019,538.00 |
DisclosureSEC source: 0001628280-24-042686 · wk-form4_1728601055.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,543,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.01 to $11.92. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:16 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $11.70 | $1,052,874.00 |
DisclosureSEC source: 0001628280-24-040790 · wk-form4_1726690586.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,633,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.43 to $12.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| March 25, 2024 Filed Jul 11, 2025 21:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | Tax withholdingCommon Stock | 33,319 | $4.63 | $154,266.97 |
DisclosureSEC source: 0001628280-25-034810 · wk-form4_1752268473.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,888,586 F1 · shares: Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction. Vesting occurred on 3/25/2024 and the transaction is being reported late due to an inadvertent administrative oversight. F2 · balance_after: Reflects the number of shares beneficially owned as of the date of this Form 4. The number of shares beneficially owned immediately following the reported transaction was 2,710,653. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 21:27 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | PurchaseCommon Stock | 103,000 | $4.82 | $496,779.30 |
DisclosureSEC source: 0001209191-24-004895 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,745,253 F1 · kind: The transaction reported on this Form 4 is an open-market purchase by the reporting person of 103,000 shares of common stock at a weighted-average purchase price per share of $4.8231. F2 · price: The reported price in column 4 is a weighted-average price. Shares were purchased in multiple transactions at a per share price ranging from $4.77 to $4.87. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range. Read SEC document |
| March 13, 2024 Filed Mar 16, 2024 00:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 330,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004881 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,642,253 F1 · kind: Represents 330,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 22:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | Tax withholdingCommon Stock | 34,520 | $5.39 | $186,062.80 |
DisclosureSEC source: 0001209191-24-004788 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,312,253 F1 · shares: Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction. Read SEC document |
| March 08, 2024 Filed Jul 11, 2025 21:07 UTC Amendment | Alignment Healthcare, Inc. ALHC · Entity 4269 | Tax withholdingCommon Stock | 35,801 | $5.39 | $192,967.39 |
DisclosureSEC source: 0001628280-25-034806 · wk-form4a_1752268073.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,310,972 F1 · shares: Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 21:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 34,506 | $6.11 | $210,945.53 |
DisclosureSEC source: 0001209191-23-021892 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,346,773 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 22:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 39,101 | $6.33 | $247,392.03 |
DisclosureSEC source: 0001209191-23-018985 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381,279 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 23:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 1,100 | $13.01 | $14,310.01 |
DisclosureSEC source: 0001209191-23-004324 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,723,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| December 01, 2022 Filed Dec 3, 2022 00:21 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 25,000 | $13.11 | $327,777.50 |
DisclosureSEC source: 0001209191-22-059508 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,724,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.38. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 20:25 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 25,000 | $13.23 | $330,830.00 |
DisclosureSEC source: 0001209191-22-055287 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,749,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.08 to $13.38. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:23 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 25,000 | $13.07 | $326,855.00 |
DisclosureSEC source: 0001209191-22-054805 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,774,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| September 12, 2022 Filed Sep 13, 2022 22:30 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 1,639,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-049765 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,420,380 F1 · kind: Represents 1,639,027 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 50% on each of the third and fourth anniversaries of the grant date, subject to the reporting person's continued service to the Company. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:13 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 50,000 | $14.56 | $727,935.00 |
DisclosureSEC source: 0001209191-22-048485 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,799,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.3050 to $14.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:32 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 500,000 | $15.95 | $7,976,450.00 |
DisclosureSEC source: 0001209191-22-045615 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,849,200 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.95 to $16.67. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:31 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,003 | $19.01 | $76,110.24 |
DisclosureSEC source: 0001209191-22-045003 · doc4.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,349,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.00 to $19.14. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:31 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 62,188 | $18.54 | $1,152,778.96 |
DisclosureSEC source: 0001209191-22-045003 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,353,203 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.00 to $18.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 01:18 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 848 | $14.74 | $12,499.52 |
DisclosureSEC source: 0001209191-22-044009 · doc4.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,415,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 01:18 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 49,152 | $14.60 | $717,594.62 |
DisclosureSEC source: 0001209191-22-044009 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,416,239 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 11, 2022 Filed Jul 11, 2022 21:55 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,107 | $14.08 | $57,808.08 |
DisclosureSEC source: 0001209191-22-041837 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,465,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.00 to $14.42. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 22:41 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 20,699 | $14.33 | $296,546.29 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 4 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,469,498 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F6 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.10 to $14.56. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:41 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 7,370 | $14.29 | $105,349.73 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,490,197 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.16 to $14.35. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:41 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 42,072 | $13.88 | $583,841.56 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,497,567 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.15 to $14.14. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 22:41 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 25,752 | $13.04 | $335,924.54 |
DisclosureSEC source: 0001209191-22-041712 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,539,639 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.23. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (4), (5) and (6) to this Form 4. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 22:49 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 26,366 | $11.18 | $294,655.87 |
DisclosureSEC source: 0001209191-22-022069 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,353 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:21 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantOptions (Right to Buy) · Derivative | 364,964 | $0.00 Strike: $9.06 | $0.00 |
DisclosureSEC source: 0001209191-22-018000 · doc4.xml · derivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,964 Underlying: Common Stock · 364,964 shares Expires 2032-03-08 F3 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 22:21 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 496,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018000 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,719 F1 · kind: Represents 496,689 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 23:31 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 419,646 | $20.11 | $8,438,031.95 |
DisclosureSEC source: 0000950142-21-003814 · es210205304_4-kao.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,565,391 F1 · kind: Represents 419,646 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") sold pursuant to a registered offering which closed on November 23, 2021, at a price of $20.1075 (net of underwriting discount). F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:56 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 29,302 | $19.93 | $583,941.98 |
DisclosureSEC source: 0001209191-21-062729 · doc4.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,985,037 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted-average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (4) to this Form 4. F4 · price: The shares were sold in multiple transactions at prices ranging from $19.58 to $20.45 per share. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:56 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 70,698 | $19.91 | $1,407,674.95 |
DisclosureSEC source: 0001209191-21-062729 · doc4.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,014,339 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted-average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (4) to this Form 4. F2 · price: The shares were sold in multiple transactions at prices ranging from $19.37 to $20.18 per share. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 23:39 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 43,097 | $18.83 | $811,434.63 |
DisclosureSEC source: 0000950142-21-003198 · es210192796_4-kao.xml · nonDerivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,085,037 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4. Transactions within a $1.00 price range are reported in accordance with the June 25, 2008 SEC No-Action letter. F5 · price: The shares were sold in multiple transactions at prices ranging from $18.23 to $19.05 per share. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 23:39 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 1,262 | $19.00 | $23,979.64 |
DisclosureSEC source: 0000950142-21-003198 · es210192796_4-kao.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,128,134 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4. Transactions within a $1.00 price range are reported in accordance with the June 25, 2008 SEC No-Action letter. F4 · price: The shares were sold in multiple transactions at prices ranging from $19.00 to $19.025 per share. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 23:39 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock, par value $0.001 per share ("Common Stock") | 155,641 | $18.44 | $2,870,595.91 |
DisclosureSEC source: 0000950142-21-003198 · es210192796_4-kao.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,129,396 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4. Transactions within a $1.00 price range are reported in accordance with the June 25, 2008 SEC No-Action letter. F2 · price: The shares were sold in multiple transactions at prices ranging from $18.00 to $18.97 per share. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.